Napoleone Ferrara
Founder at Theia Therapeutics, Inc.
Profile
Napoleone Ferrara is the founder of Theia Therapeutics, Inc. He currently holds positions as Director at Inflammasome Therapeutics, Inc., Scientific Advisory Board member at Gemini Pharmaceuticals, Inc., Professor at the University of California, and Venture Partner at Catalio Capital Management LP.
He formerly held positions as Independent Director at Kintara Therapeutics, Inc. and Senior Scientist at Genentech, Inc. Ferrara earned a doctorate degree from the University of Catania.
Napoleone Ferrara active positions
| Companies | Position | Start |
|---|---|---|
| University of California | Corporate Officer/Principal | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
| Theia Therapeutics, Inc. | Founder | - |
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Consultant / Advisor | - |
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Director/Board Member | - |
Former positions of Napoleone Ferrara
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| KINTARA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Napoleone Ferrara
| University of Catania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KINTARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
| Theia Therapeutics, Inc. | |
Gemini Pharmaceuticals, Inc.
Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Stock Market
- Insiders
- Napoleone Ferrara
